Search

Displaying results 2621 - 2630 of 10000 in total
  1. Indication

    Albuminuria

    go.drugbank.com/conditions/DBCOND0001408
    Drugs: Azilsartan medoxomil
    Synonyms: Abnormal presence of protein in urine
  2. Indication

    Pyelonephritis

    go.drugbank.com/conditions/DBCOND0014040
    Drugs: Cefepime · Cefiderocol · Cilastatin · Doripenem · Escherichia coli · Imipenem +6 more
    Synonyms: Renal tubulo-interstitial disorders in diseases classified elsewhere (disorder)
  3. Drug

    Thiamphenicol

    go.drugbank.com/drugs/DB08621
    Investigational

    Products: URFAMYCIN 750 MG IM/IV ENJEKTABL TOZ İÇEREN FLAKON, 1 FLAKON + 1 AMPUL
  4. Drug

    Vamorolone

    go.drugbank.com/drugs/DB15114
    ApprovedInvestigational

    Vamorolone is a novel and fully synthetic glucocorticoid developed by Santhera Pharmaceuticals. … It is used to manage inflammation and immune dysregulation in patients with Duchenne muscular dystrophy (DMD), a neuromuscular disorder characterized by the insidious regression of neuromuscular function

    Categories: Sex Hormones and Insulins
  5. Indication

    Systemic Anaplastic Large Cell Lymphoma

    go.drugbank.com/conditions/DBCOND0079449
    Drugs: Brentuximab vedotin
    Synonyms: Anaplastic large cell lymphoma, T cell and null cell type, Large cell anaplastic lymphoma T cell and null cell type (disorder)
  6. Drug

    Gliclazide

    go.drugbank.com/drugs/DB01120
    ApprovedInvestigational

    Gliclazide is extensively metabolized by the liver; its metabolites are excreted in both urine (60-70%) and feces (10-20%). … Gliclazide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM).

    Categories: Drugs Used in Diabetes, Alimentary Tract and MetabolismProducts: Gliavis IR Tablet 80mg, Rolazide Tablet 80mg
  7. Drug

    Berahyaluronidase alfa

    go.drugbank.com/drugs/DB22790
    ApprovedInvestigational

    This combination was approved by the US FDA in September 2025 and is indicated for various solid tumors in adults and pediatric patients 12 years and older, offering a subcutaneous option for indications … It is used in a fixed-dose combination with [pembrolizumab] for subcutaneous injection.

    Categories: Enzymes and Coenzymes
  8. Drug

    Inulin

    go.drugbank.com/drugs/DB00638
    ApprovedInvestigationalNutraceutical

    A starch found in the tubers and roots of many plants. Since it is hydrolyzable to fructose, it is classified as a fructosan. … It has been used in physiologic investigation for determination of the rate of glomerular function.

    Categories: Compounds used in a research, industrial, or household setting, inulin and other polyfructosans
  9. Drug

    Linaclotide

    go.drugbank.com/drugs/DB08890
    ApprovedInvestigational

    Linaclotide is a synthetic 14-amino acid cyclic peptide [A260271] and first-in-class guanylate cyclase-C (G-CC) agonist. … [A260271] It gained EMA and Health Canada approval on November 26, 2012 [L47216] and December 3, 2013,[L47221] respectively.

    Categories: Alimentary Tract and Metabolism, Amino Acids, Peptides, and Proteins
  10. Drug

    Patisiran

    go.drugbank.com/drugs/DB14582
    Approved

    The approval for Onpattro was granted to Alnylam Pharmaceuticals, Inc. in August of 2018. Onpattro has been granted Fast Track, Priority Review and Breakthrough Therapy, and Orphan Drug designations. … Patisiran is a first in class short interfering RNA for the treatment of patients with polyneuropathy caused by hereditary transthyretin-mediated amyloidosis [L4220].

    Categories: Nucleic Acids, Nucleotides, and Nucleosides, Compounds used in a research, industrial, or household setting